Jenne Kyle bought IONS
January 15, 2026 · Form 4 insider transaction
Jenne Kyle bought 7,013 shares of Ionis Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,013
Price
$0.00
Total value
N/A
InsiderJenne Kyle
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 15, 2026
Filing dateJanuary 20, 2026
Shares owned after18,212
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards.